Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × ACTH-Secreting Pituitary Adenoma × Cabergoline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pituitary Neoplasms 7 Prolactinoma 4 Pituitary ACTH Hypersecretion 3 Polycystic Ovary Syndrome 2 Acromegaly 2 Recurrence 1 Prostatic Neoplasms 1 Ovarian Hyperstimulation Syndrome 1 Neuroendocrine Tumors 1 Neoplasms 1 Melanoma 1 Hyperprolactinemia 1 Dumping Syndrome 1 Breast Neoplasms 1 Brain Neoplasms 1 Adrenocortical Hyperfunction 1 Adenoma 1 ACTH-Secreting Pituitary Adenoma 1

Interventions

Early Intervention, Educational 1 Cabergoline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00889525 2009-04-29

Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor

Seth Gordhandas Sunderdas Medical College

Phase 3 Completed

Pituitary ACTH Hypersecretion, ACTH-Secreting Pituitary Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡